Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Eng

Showing results (231-240 of 315) with videos related to

Pageof 32
Sort By:
British Journal of Cancer|August 14, 2019
Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinomaKrittiya Korphaisarn, Van Morris, Jenifer S Davis, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinomaEmma B Holliday, Andrew Hunt, Y Nancy You, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal CanalVan K Morris, Suyu Liu, Kangyu Lin, et al.
JCO Precision Oncology|September 11, 2020
Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal CancerBenny Johnson, Jonathan M Loree, Alexandre A Jacome, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2021
First-in-Human PET Imaging and Estimated Radiation Dosimetry of l-[5-<sup>11</sup>C]-Glutamine in Patients with Metastatic Colorectal CancerAllison S Cohen, Joe Grudzinski, Gary T Smith, et al.
Cancer|October 4, 2013
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapyAtin Agarwal, George J Chang, Chung-Yuan Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2024
Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO GuidelineVan K Morris, Erin B Kennedy, Manik A Amin, et al.
International Journal of Radiation Oncology, Biology, Physics|October 24, 2006
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysisPrajnan Das, Edward H Lin, Sumita Bhatia, et al.
Oncotarget|July 16, 2016
MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenonKanwal Raghav, Van Morris, Chad Tang, et al.
Cancer|December 23, 2023
Data-driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancerLauren M Janczewski, Amanda Browner, Joseph Cotler, et al.
Pageof 32

Showing results (231-240 of 315) with videos related to

Sort By:
Pageof 32
British Journal of Cancer|August 14, 2019
Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinomaKrittiya Korphaisarn, Van Morris, Jenifer S Davis, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinomaEmma B Holliday, Andrew Hunt, Y Nancy You, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal CanalVan K Morris, Suyu Liu, Kangyu Lin, et al.
JCO Precision Oncology|September 11, 2020
Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal CancerBenny Johnson, Jonathan M Loree, Alexandre A Jacome, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2021
First-in-Human PET Imaging and Estimated Radiation Dosimetry of l-[5-<sup>11</sup>C]-Glutamine in Patients with Metastatic Colorectal CancerAllison S Cohen, Joe Grudzinski, Gary T Smith, et al.
Cancer|October 4, 2013
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapyAtin Agarwal, George J Chang, Chung-Yuan Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2024
Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO GuidelineVan K Morris, Erin B Kennedy, Manik A Amin, et al.
International Journal of Radiation Oncology, Biology, Physics|October 24, 2006
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysisPrajnan Das, Edward H Lin, Sumita Bhatia, et al.
Oncotarget|July 16, 2016
MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenonKanwal Raghav, Van Morris, Chad Tang, et al.
Cancer|December 23, 2023
Data-driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancerLauren M Janczewski, Amanda Browner, Joseph Cotler, et al.
Pageof 32